cerrar
Tagged with R&D

China: A New Biopharma Model Emerging
Professor Richard Barker, founder of New Medicine Partners reflects on China's very different approach to the biopharma industry. Napoleon…

Stanislas Lyonnet – Director, Imagine Institute, France
Prof. Stanislas Lyonnet, director of the Imagine Institute in Paris, France, explains his organization’s unique ecosystem that brings together…

Radwa Terbeche – General Manager, Amgen Algeria
Radwa Terbeche, general manager of Amgen in Algeria discusses the potential for biosimilars in Algeria and the company’s role in developing a local…

One Business or Two? The Era of Precision Medicine
In my career, I’ve held senior roles in both the biopharma and diagnostics sectors. Working across different cost structures, different business…

Roche boss: Brexit will make the UK less competitive
Last week, Roche Boss Severin Schwan expressed concern that Brexit could further slow the UK drug approval process. After the UK’s recent divorce…

Michael Yang – Head & Chair Professor of the…
Prof. Michael Yang, an accomplished scientist and start-up expert, introduces the goals of the fast-growing Biomedical Sciences Department of City…

NEW Special Report on UK
Despite a myriad of uncertainties around its decision to leave the European Union, the UK still stands as one of the world’s premier life science…

Renan Ozyerli, MD, MSD Turkey
Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the past decade, highlighting how MSD…

UK Charities: The Funding Giants of Medical Research
One notable quirk of the British life sciences ecosystem is the importance of its not-for-profit sector. Indeed, in 2017, UK charities poured GBP 1.6…

Interview: Ken Sutherland – President, Canon Medical…
With a strong historic footprint in Edinburgh, Canon Medical Systems has based one of its global R&D centres in Scotland from where it develops…

Chris Fox – General Manager, Amgen UK & Ireland
Christine (Chris) Fox, VP and general manager UK and Ireland at Amgen, two months into her first country manager position and first time in a role…

GSK Curbs Rumours of a Consumer Health Cull in Q2
In a pharmaceutical environment faced with stiffening regulatory regimes, and where mergers and acquisitions become more commonplace, GSK’s…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here